in alphabetical order:

Timothy R. AksamitConsultant, Mayo Clinic, Pulmonary Disease and Critical Care Medicine, Rochester, USA
on "Report from the EMBARC/BRR working group on bronchiectasis outcomes defintions"
confirmed

Marta AlmagroBarcelona, Spain
on "A patients' perspective"
confirmed

Alan BarkerPneumologist, Oregon, USA
on “Inhaled antibiotics – potential an pitfalls”
confirmed

James ChalmersSchool of Medicine, University of Dundee, Schottland
on “Omics approaches to understand airway inflammation in bronchiectasis”
confirmed

Anthony De SoyzaMedical School, Newcastle University, UK
on “The Future: what is next in bronchiectasis?”
confirmed

Lieven DupontUniversity Hospital Gasthuisberg, Katholieke Universiteit Leuven, Belgium
on “Lost in translation? Therapeutic contrasts in CF and non-CF bronchiectasis”
confirmed

Stuart ElbornSchool of Medicine, Dentistry and Biomedical Sciences, Queens University, Belfast, Nothern Ireland
on “Molecular diagnosis of infection and resistance”
confirmed

Andres FlotoCambridge Institute for Medical Research, University of Cambridge, UK
on “Understanding the role of NTM”
confirmed

Charles HaworthDirector of Thoracic Services, Papworth Hospital, Cambridge, UK
on "Report from the EMBARC/BRR working group on bronchiectasis outcomes defintions"
confirmed

Adam HillDepartment of Respiratory Medicine, Royal Infirmary of Edinburgh, UK
on "Report from the EMBARC/BRR working group on bronchiectasis outcomes defintions"
confirmed

John HurstCentre for Inflammation and Tissue Repair, University College London, UK
on “COPD and bronchiectasis - a real phenotype?“
confirmed

Anne O`DonnellGeorgetown University Medical Center, Georgetown University, USA
on “The Present: Bronchiectasis in 2016”
confirmed

Eva PolverinoRespiratory Diseases Department, Institut Clínic del Tòrax, Hospital Clinic i Provincial de Barcelona, Spain
on "Asthma und bronchiectasis"
confirmed

Alexandra L. QuittnerDepartment of Psychology, Miami College of Arts and Science, USA
on “Quality of life as an outcome measure in clinical trials”
confirmed

Felix C. RingshausenDept. of Resp. Medicine, Hannover Medical School, Germany
on “Non-CF bronchiectasis: a spectrum of CFTR dysfunction?”
confirmed

Geraint RogersFlinders Medical School, South Australian Health and Medical Research Institute, Australia
on “Microbiota composition and disease severity in bronchiectasis”
confirmed

Thomas RuddyGermany, Switzerland and USA
on "A patients' perspective"
confirmed

Michael G. SuretteUniversity of Calgary, Canada
on “Introducing the microbiome, lesson from the healthy lung and CF”
confirmed

Gregory TinoHospital of the University of Pennsylvania, USA
on "Infection or inflammation: Chicken or egg - implications for treatment"
confirmed

Menno van der EerdenErasmus Universiteit Rotterdam, The Netherlands
on "Translating treatments between COPD and bronchiectasis”
confirmed

Tobias WelteDept. of Resp. Medicine, Hannover Medical School, Germany
Introduction
confirmed

Robert WilsonConsultant physician, NHS, UK
on “The past: The renaissance of bronchiectasis”
confirmed

Conroy WongPneumologist, Middlemore Hospital, New Zealand
on “Macrolides: known knowns, and known unknowns”
confirmed